BerGenBio
Clinical-stage biopharma that developed selective AXL kinase inhibitors for cancer.
BGBIO | OL
Overview
Corporate Details
- ISIN(s):
- NO0012921180 (+2 more)
- LEI:
- 213800TYYFXKYF3V2A23
- Country:
- Norway
- Address:
- MØLLENDALSBAKKEN 9, 5009 BERGEN
- Website:
- https://www.bergenbio.com/
- Sector:
- Manufacturing
Description
BerGenBio was a clinical-stage biopharmaceutical company focused on developing first-in-class selective AXL kinase inhibitors. The company's therapeutic candidates targeted AXL as a potential cornerstone of therapy for aggressive, advanced, and treatment-resistant cancers. In October 2025, BerGenBio completed a merger with Oncoinvent ASA, and the combined entity was renamed Oncoinvent.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2020-07-03 05:00 |
BerGenBio ASA: Last day of subscription period in the subsequent offering
|
English | 223.2 KB | ||
| 2020-07-03 05:00 |
BerGenBio ASA: Last day of subscription period in the subsequent offering
|
English | 8.5 KB | ||
| 2020-07-02 14:38 |
BerGenBio ASA: Primary Insider notification
|
English | 668 bytes | ||
| 2020-07-01 14:41 |
BerGenBio ASA: Primary Insider notification
|
English | 670 bytes | ||
| 2020-06-25 17:05 |
BERGENBIO ANNOUNCES POSITIVE interim CLINICAL AND TRANSlaTIONAL DATA from Phase…
|
English | 238.1 KB | ||
| 2020-06-25 17:05 |
BERGENBIO ANNOUNCES POSITIVE interim CLINICAL AND TRANSlaTIONAL DATA from Phase…
|
English | 8.1 KB | ||
| 2020-06-24 05:00 |
BerGenBio announces change to presentation time at Next Gen Immuno-Oncology Con…
|
English | 224.8 KB | ||
| 2020-06-24 05:00 |
BerGenBio announces change to presentation time at Next Gen Immuno-Oncology Con…
|
English | 5.2 KB | ||
| 2020-06-23 05:00 |
BerGenBio to Present at the Upcoming Virtual European Biotech Investor Day 2020
|
English | 4.2 KB | ||
| 2020-06-19 14:38 |
BerGenBio ASA: Commencement of the subsequent offering
|
English | 100.1 KB | ||
| 2020-06-19 14:38 |
BerGenBio ASA: Commencement of the subsequent offering
|
English | 10.8 KB | ||
| 2020-06-19 14:37 |
BerGenBio ASA: Approval of Prospectus
|
English | 95.4 KB | ||
| 2020-06-19 14:37 |
BerGenBio ASA: Approval of Prospectus
|
English | 9.0 KB | ||
| 2020-06-19 14:35 |
BerGenBio ASA: Resolution to carry out a share capital increase in connection w…
|
Norwegian | 514.2 KB | ||
| 2020-06-19 14:35 |
BerGenBio ASA: Resolution to carry out a share capital increase in connection w…
|
English | 98.2 KB |
Automate Your Workflow. Get a real-time feed of all BerGenBio filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for BerGenBio
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for BerGenBio via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
